Agilent Technologies reports strong growth in first quarter of 2018

Agilent Technologies has announced its financial results for the first quarter of 2018, during which it generated revenues of $1.21 billion (GBP 865.67 million).

For the three months ending on January 31st 2018, revenues were up by 14 percent year-on-year, or ten percent on a core basis, maintaining the positive momentum the company experienced during 2017.

The firm's life science and applied markets group grew 14 percent year over year, with broad strength across all major end markets, while the CrossLab group saw good momentum for services and consumables, with 12 percent growth for the unit.

Meanwhile, its diagnostics and genomics group grew 13 percent year-on-year, led by strong demand for pathology products and companion diagnostics services.

Mike McMullen, Agilent's chief executive officer and president, said: "Looking forward, we will keep our focus on driving sustainable above-market growth and delivering value to shareholders through the execution of our proven strategy. Overall, we are well-positioned to continue delivering excellent operating results."

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.